General discussion, page-7346

Hi TV,
Thanks for the reply. Based on the info you provided, below is my back of the envelope estimation.
Dsiclosure: I dont have a bio/med background so I might have grossly over/under estimated the potential of upcoming milestones. Please feel free to correct me and adjust the projections.

	Timeline	Expected Events	Share Price Projection
1	Dec 2021	1.IHL 42X – Complete Phase 2 Trials – Submit FDA Pre-IND 2.IHL – 216A - Complete Phase 2 Trials – Submit FDA Pre-IND 3.IHL 675A – Complete Phase 1 Trials (IBD, ILD, RA) 4.PSI – GAD (Commence Phase 2A trials)	75 – 99 Cents
2	March 2022	1.IHL 675A - Submit FDA Pre-IND	$0.8 to $1.2
3	September 2022	1.IND submission for IHL 42X 2.IND submission for IHL 216A 3.Submission of FDA Pre-IND for Phase 2 trials of IHL 675 A )(IBD, ILD) 4.IND Submission for PSI – General Anxiety Disorder	$1 - $1.5
4	June 2023	1.IND submission for IHL 675 (RA)	$1.2 - $1.75